Across TCGA pan-cancer cohorts, FRG2MP RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated FRG2MP data layer.
The strongest signal is observed in kidney chromophobe (KICH), where higher FRG2MP RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FRG2MP expression acts as an unfavorable survival marker, although some lineages such as STAD and UCS show a favorable association.
KICH, STAD, and COAD are the cancer types where FRG2MP RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.